Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Vaccine. 2020 Mar 17;38(18):3411–3421. doi: 10.1016/j.vaccine.2020.03.014

Table 1. Summary of demographic characteristics at Vitamin A administration and/or RTS,S/AS01 vaccination - exposed set.

RTS,S coad RTS,S alone Control
N = 231 N = 236 N = 232
Age (months), mean ± SD 6.3 ± 0.3 6.3 ± 0.3 6.3 ± 0.3
Male gender, n (%) 115 (49.8) 117 (49.6) 119 (51.3)
Mean length for age Z-score ± SD −0.5 ± 1.0 −0.5 ± 1.1 −0.6 ± 1.1
Mean weight for age Z-score ± SD −0.8 ± 1.1 −0.7 ± 1.1 −0.8 ± 1.1

RTS,S coad, children who received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age and the YF and MR vaccines at 9 months of age; RTS,S alone, children who received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age; Control, children who received the YF and MR vaccines at 9 months of age; N, number of children; SD, standard deviation; n (%), number (percentage) of children in a given category; Z-score, SD score calculated as: (observed value minus the median value of the reference population) / standard deviation value of the reference population; YF, yellow fever; MR, combined measles-rubella. At Visit 2, RTS,S/AS01 was given with Vitamin A in the RTS,S coad and the RTS,S alone groups and the Control group received only Vitamin A.